Background The emergence of immunotherapy has changed the treatment modality for
melanoma and prolonged the survival of many patients. However, a handful of patients …

Purpose With the rapid development of immunotherapy, cancer treatment has entered a new
phase. Medical imaging, as a primary diagnostic method, is closely related to cancer …

Background Early tumor shrinkage (ETS) has been identified as a promising imaging
biomarker for patients undergoing immunotherapy for several cancer entities. This study …

The development of in vitro/in vivo translational methods and a clinical trial framework for
synergistically acting drug combinations are needed to identify optimal therapeutic …

Background Small-cell lung cancer (SCLC) is a leading cause of cancer-related death.
However, the prognostic value of the tumor shrinkage rate (TSR) after chemotherapy for …